Den 21. april 2022 blev der afholdt ordinær generalforsamling i Reponex Pharmaceuticals A/S, CVRnr. 30082346.
Advokat Martin Allan Christensen blev udpeget til dirigent, jf. vedtægternes pkt. 3.6.
Den 21. april 2022 blev der afholdt ordinær generalforsamling i Reponex Pharmaceuticals A/S, CVRnr. 30082346.
Advokat Martin Allan Christensen blev udpeget til dirigent, jf. vedtægternes pkt. 3.6.
Pharma Equity Group A/S
Slotsmarken 18, 2.th.
DK-2970 Hørsholm
Denmark
CVR 26791413
For general enquiries contact us at info@pharmaequitygroup.com
For Investor related enquiries contact us at investor@
For any drug quality issues, complaints or adverse events,
contact us at quality@reponex.dk
All rights reserved
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |